ArticleThe Korean journal of internal medicine2026
Prognostic analysis according to adjuvant chemotherapy and anti-HER2 therapy following surgery in T1a/b HER2-positive breast cancer.
Woochan Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.